发明名称 ORAL IMMUNIZATION WITH PAPILLOMAVIRUS VIRUS-LIKE PARTICLES
摘要 <p>The present invention is directed to a method of expressing the papillomavir us capsid protein coding sequence in a cell using an expression system under conditions facilitating expression of the protein in the cell. In another aspect of the invention, it has been discovered that virus-like particle(s) (VLPs), fragment(s), capsomer(s) or portion(s) thereof are formed from the papillomavirus capsid protein. It was further discovered that the virus-like particle(s) comprises antigenic characteristics similar to those of native infectious papillomavirus particles. In one embodiment of the invention, the re is provided a method of expressing the L1 major capsid protein of human papillomavirus type-6 (HPV-6) and type-11 (HPV-11) in Sf-9 insect cells usin g the baculovirus expression system, and the production of type 6 (HPV-6), typ e- 11 (HPV-11), type-16 (HPV-16) and type-18 (HPV-18) virus-like particles. In yet another embodiment, the invention provides a method of vaccinating a mammal for papillomavirus by administering papillomavirus virus-like particl es orally to a mammal in an amount sufficient to induce an immune response to t he papillomavirus.</p>
申请公布号 CA2329136(A1) 申请公布日期 1999.12.02
申请号 CA19992329136 申请日期 1999.05.27
申请人 UNIVERSITY OF CAPE TOWN;UNIVERSITY OF ROCHESTER 发明人 RYBICKI, EDWARD P.;WILLIAMSON, ANNA-LISE;ROSE, ROBERT C.
分类号 G01N33/53;A61K35/12;A61K35/64;A61K39/00;A61K39/12;A61K39/395;A61P31/12;A61P35/00;A61P37/04;C07K14/025;C12N5/10;C12N7/04;C12N15/09;C12N15/37;C12P21/02;G01N33/569;(IPC1-7):A61K39/12 主分类号 G01N33/53
代理机构 代理人
主权项
地址